AHA to CMS Re: Medicare Program: Electronic Prescribing of Controlled Substances; Request for Information (RFI)

AHA provides input on the Centers for Medicare & Medicaid Services’ (CMS) Request for Information (RFI) regarding electronic prescribing of controlled substances (EPCS). The RFI solicits comments on whether CMS should include exceptions to the EPCS requirements laid forth in Section 2003 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, and whether CMS should impose penalties for noncompliance.

Related Resources

Testimony
Public
Statement of the American Hospital Association to the Committee on Finance of the United States Senate “Protecting Youth Mental Health: Part II - Identifying…
Letter/Comment
Public
AHA letter to Representative Donald Norcross expressing support for bipartisan legislation, the Opioid Treatment Access Act (H.R. 6279).
Advancing Health Podcast
Public
In this episode, Marie Cleary-Fishman, vice president of clinical quality at the AHA Center for Health Innovation is joined by Dr. Holly Geyer, internal…
Letter/Comment
Public
In a letter to Representatives Bradley Schneider,  David McKinley and Annie Kuster, the AHA expresses support for bipartisan legislation, the Substance Use…
Letter/Comment
Public
In a letter to Senators Margaret Wood Hassan and Susan Collins, the AHA expresses support for bipartisan legislation, the Opioid Workforce Act of 2021 (S. 1438…
Case Studies
Public
Norton Healthcare serves the Louisville and Southern Indiana market. Its 373-bed Norton Women’s…